“…3 Exploring these clinical dilemmas, Htun and Lee summarize the evidence on the efficacy and safety of primary thromboprophylaxis in cancer patients undergoing surgery, also taking into account the influence of cancer type on thromboembolic risk; they also present the current consensus recommendations in this setting. 4 Pediatric cardiac surgery affords special challenges in regard to management of hemostasis. First of all, hemostasis in children differs from that in adults, 5 making interpretation of laboratory tests challenging.…”